BlattnerW., GalloR.C., TeminH.M.. HIV causes AIDS. In: DuesbergP.H., ed. Infectious HIV: have we been misled?Berkeley, California: North Atlantic Books, 1995; 80–2.
2.
TokarsJ.I., MillerE.R., AlterM.J., ArduinoM.J.. National surveillance of dialysis-associated diseases in the United States, 1997.Semin Dial2000; 13: 75–85.
3.
TokarsJ.I., MillerE.R., AlterM.J., ArduinoM.J.. National surveillance of dialysis-associated diseases in the United States, 1995.ASAIO J1998; 44: 98–107.
4.
MorrisonA.J., FreerC.V., PooleC.L.. Prevalence of human T-lymphotropic virus type III antibodies among patients in dialysis programs at a university hospital.Ann Intern Med1986; 104: 805–7.
5.
De RossiA., VertolliU., RomagnoliG., BertoliM., Dalla GassaO., Chieco-BianchiL.. LAV/HTLV II and HYLV I antibodies in hemodialysis patients (Letter).Nephron1986; 44: 377–8.
6.
Baltimore-Boston Collaborative Study Group.Human immunodeficiency virus infection in hemodialysis patients.Arch Intern Med1988; 148: 617–9.
7.
ReiserI.W., ShapiroW.B., PorushiJ.G.. The incidence and epidemiology of human immunodeficiency virus infection in 320 patients treated in an inner-city hemodialysis center.Am J Kidney Dis1990; XVI: 26–31.
8.
PerezG., Ortiz-InterianC., LeeH.. Human immunodeficiciency virus and human T-cell leukemia virus type I in patients undergoing maintenance hemodialysis in Miami.Am J Kidney Dis1989; 14: 39–43.
9.
ChirgwinK., Sreepada RaoT.K., LandesmanS.H.. HIV infection in a high prevalence hemodialysis unit.AIDS1989; 3: 731–5.
10.
Barbiano di BelgioiosoG., TrezziM., ScorzaD.. HIV infection in dialysis centers in Italy: a nationwide multicenter study.J Nephrol1998; 11: 249–54.
11.
MioliV., LombardoV., GaffiG., PerrilliA.. Epidemiologia dell'infezione da HIV nei pazienti in trattamento sostitutivo renale in Italia. In: BardelliM., BonominiV., eds. AIDS & rene.Milan, Italy: Wichtig, 1990; 53–66.
12.
PoignetJ.L., DesassisJ.F., ChantonN.. Prevalence de l'infection à HIV chez les patients dialysés: résultant d'une enquete multicentrique nationale.Nephrologie1999; 20: 159–63.
13.
IppolitoG., PuroV., De Carli V, and the Italian Study Group on Occupational Risk of HIV Infection. The risk of occupational human immunodeficiency virus infection in health care workers.Arch Intern Med1983; 153: 1451–8.
14.
DuesbergP.H.. Human immunodeficiency virus and acquired immunodeficiency virus syndrome: correlation but not causation.Proc Natl Acad Sci USA1989; 86: 755–64.
15.
AlterM.J., FaveroM.S., PetersenN.J., DotoI.L., LegerR.T., MaynardJ.E.. National surveillance of dialysis-associated hepatitis and other diseases 1976–1980.Dial Transplant1983; 12: 860–5.
16.
AlterM.J., FaveroM.S., MillerI.K., MoyerL.A., BlandL.A.. National surveillance of dialysis-associated diseases in the United States, 1987.ASAIO Trans1989; 35: 820–31.
17.
AlterM.J., FaveroM.S., MillerI.K., MoyerL.A., BlandL.A.. National surveillance of dialysis-associated diseases in the United States, 1988.ASAIO Trans1990; 36: 107–18.
18.
AlterM.J., FaveroM.S., MillerI.K., MoyerL.A., BlandL.A.. National surveillance of dialysis-associated diseases in the United States, 1989.ASAIO Trans1981; 37: 97–109.
19.
TokarsJ.I., AlterM.J., FaveroM.S., MoyerL.A., BlandL.A.. National surveillance of dialysis-associated diseases in the United States, 1990.ASAIO J1993; 39: 71–80.
20.
TokarsJ.I., AlterM.J., FaveroM.S., MoyerL.A., BlandL.A.. National surveillance of dialysis-associated diseases in the United States, 1991.ASAIO J1993; 39: 966–75.
21.
TokarsJ.I., AlterM.J., FaveroM.S., MoyerL.A., MillerE., BlandL.A.. National surveillance of dialysis-associated diseases in the United States, 1992.ASAIO J1994; 40: 1020–31.
22.
TokarsJ.I., AlterM.J., FaveroM.S., MoyerL.A., MillerE., BlandL.A.. National surveillance of dialysis-associated diseases in the United States, 1993.ASAIO J1996; 42: 219–29.
23.
TokarsJ.I., AlterM.J., MillerE., MoyerL.A., FaveroM.S.. National surveillance of dialysis-associated diseases in the United States, 1994.ASAIO J1997; 43: 109–19.
24.
MarcusR., FaveroM.S., BanerjeeS.. The Cooperative Dialysis Study Group. Prevalence and incidence of human immunodeficiency virus among patients undergoing long-term hemodialysis.Am J Med1991; 90: 614–9.
25.
PetrosilloN., PuroV., IppolitoG., and The Italian Multicentric Study on Nosocomial and Occupational Risk of Blood-Borne Infections in Dialysis. Prevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among dialysis patients.Nephron1993; 64: 636–9.
26.
OrtizC., MenesesR., JaffeD., FernandezJ.A., PerezG., BourgoignieJ.J.. Outcome of patients with human immunodeficiency virus on maintenance hemodialysis.Kidney Int1988; 34: 248–53.
27.
YuasaT., IshikawaG., ManabeS., SekiguchiS., TakeuchiK., MiyamuraT.. The particle size of hepatitis C virus estimated by filtration through microporous regenerated cellulose fibre.J Gen Virol1991; 72: 2021–4.
28.
IppolitoG., PetrosilloN., GuzzantiE.. Rischio di infezione da HIV e da altri patogeni a trasmissione ematica in emodialisi e misure di prevenzione adottabili.Giorn It AIDS1999; 3: 189–202.
29.
CerraiT., TotiG., PaoliniR.. La sanitizzazione dei monitor per dialisi e i patogeni ematogeni virali.Giorn It Nefrol1999; 16: 168–79.
30.
TeixidoJ., ArgelaguesE., CaralpsA.. Anti-HTLV-III antibodies in dialyzed or transplanted patients in Spain (Letter).Nephron1987; 46: 325–6.
31.
AhujaT.S., NiazN., VelascoA., WattsB., PaarD.. Effect of hemodialysis and antiretroviral therapy on plasma viral load in HIV-1 infected hemodialysis patients.Clin Nephrol1999; 51: 40–4.
32.
Centers for Disease Control and Prevention. Update.Investigations of patients who have been treated by HIV-infected health care workers.Morb Mortal Wkly Rep1992; 41: 344–6.
33.
GerderbingJ.L.. Management of occupational exposures to blood-borne viruses.N Engl J Med1995; 332: 444–51.
34.
HershB.S., PopoviciF., ApetreiR.C.. Acquired immuno-deficiency syndrome in Romania.Lancet1991; 338: 645–9.
35.
Centers for Disease Control and Prevention.Patient exposures to HIV during nuclear medicine procedures.Morb Mortal Wkly Rep1992; 41: 575–8.
36.
ChantK., LoweD., RubinG.. Patient-to-patient transmission of HIV in private surgical consulting rooms (Letter).Lancet1994; 342: 1548–9.
37.
BlankS., SimondsR.J., WeisfuseI., RudnickJ., ChiassonM.A., ThomasP.. Possible nosocomial transmission of HIV.Lancet1994; 344: 512–4.
38.
Centers for Disease Control.Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus type-III/lymphadenopathy-associated virus.Morb Mortal Wkly Rep1986; 35: 376–83.
39.
Centers for Disease Control.Recommendations for prevention of HIV transmission in health care settings.Morb Mortal Wkly Rep1987; 36(suppl. 2): 3–18.
40.
TjottaE., HungnesO., GrindeB.. Survival of HIV-1 activity after disinfection, temperature and pH changes or drying.J Med Virol1991; 35: 223–7.
41.
BloomfieldS.F., Smith-BurchnellC.A., DalgleishA.G.. Evaluation of hypochlorite releasing disinfectants against the human immunodeficiency virus (HIV).J Hosp Infect1990; 15: 273–8.
42.
GordonV., ParryS., BellamyK., OsborneR.. Assessment of chemical disinfectants against human immunodeficiency virus: overcoming the problem of cytotoxicity and the evaluation of selected actives.J Virol Methods1993; 45: 247–57.
43.
ClementM., RiccolaS.. Effect of the disinfectant formulation AMU250 vs. human immunodeficiency virus type 1 (HIV-1) in vitro.Acta Toxicologica et Therapeutica1999; XX: 53–6.
44.
BreyerJ., HarbisonM.A.. Isolation of human immunodeficiency virus from peritoneal dialysate.Am J Kidney Dis1993; 21: 23–5.
45.
WilliamsP.F., SwannB., CunninghamK.. Continuous ambulatory peritoneal dialysis fluid: Another fluid positive for HIV antibody?Br Med Journal1986; 293: 885.
46.
GoffinE., VandercamB., BurtonboyG.. Detection of HIV antigen in peritoneal dialysis fluid.Peritoneal Dial Int1994; 14: 889.
47.
ScheelP.J., FarzadeganH., FordD., MalanM., WatsonA.. Recovery of human immunodeficiency virus from peritoneal dialysis effluent.J Am Soc Nephrol1995; 5: 1926–9.
48.
KimmelP.L., VedbratS.S., PierceF.P.. Prevalence of viremia in human immunodeficiency virus-infected patients with renal disease.Arch Intern Med1955; 155: 1578–84.
49.
GilbertD.N., BennettW.. Patients with human immuno-deficiency virus infection in the hemodialysis unit.How vulnerable are the caregivers? Arch Intern Med1995; 155: 1575–6.
50.
VelandiaM., FridkinS.K., CardenasV.. Transmission of HIV in a dialysis centre.Lancet1995; 345: 1417–21.
51.
CDC.HIV transmission in a dialysis center. Colombia, 1991–1993.Morb Mortal Wkly Rep1995; 44: 404–12.
52.
El-SayedN.M., GomatosP.J., Beck-SaguèC.M.. Epidemic transmission of human immunodeficiency virus in renal dialysis centers in Egypt.J Infect Dis2000; 181: 91–7.
53.
HassanN.F., El GhoradN.M., Abdel RehimM.S.. HIV Infection in renal patients in Egypt (Letter).AIDS1994, 8: 853.
54.
Update: Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus and other blood-borne pathogens in health-care settings.MMWR1988; 37: 377–82.
55.
MMWR Update.Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings.JAMA1988; 260: 462–5.
56.
KellermannS., AlterM.J.. Preventing hepatitis B and hepatitis C virus infections in end-stage renal disease patients: back to basics.Hepatology1999; 29: 291–3.
57.
FaveroM.S., AlterM.J., BlandL.A.. Dialysis-associated infections and their control. In: BennetJ.V., BrachmanP.S., eds. Hospital infections, 3rd ed.Boston: Little, Brown, 1992; 375–403.
58.
RaoT.K.S., FriedmanE.A., NicastriA.D.. The types of renal disease in the acquired immunodeficiency syndrome.N Engl J Med1987; 316: 1062–8.
59.
OrtizC., MenesesR., JaffeD., FernandezJ.A., PerezG., BourgoigneJ.J.. Outcome of patients with human immuno-deficiency virus on maintenance hemodialysis.Kidney Int1988; 34: 248–53.
60.
KimmelP.L., UmanaW.O., SimmensS.J., WatsonJ., BoschJ.P.. Continuous ambulatory peritoneal dialysis and survival of HIV-infected patients with end-stage renal disease.Kidney Int1993; 44: 373–8.
61.
TebbenJ.A., RigsbyM.O., SelwynP.A., BrennanN., KligerG., FinkelsteinF.O.. Outcome of HIV-infected patients on continuous ambulatory peritoneal dialysis.Kidney Int1993; 44: 191–8.
62.
IfuduO., MayersD.J., MatthewJ.J.. Uremia therapy in patients with end-stage renal disease and human immunodeficiency virus infection: has the outcome changed in the 1990's?Am J Kidney Dis1997; 29: 549–52.
